Reports
17 Reports
The Director must provide declarations and reports to the Organization in accordance with Australia’s obligations under the Convention.
Schedule 1—Amendments to the Convention accepted by Australia (regulation 3AA)
[1] Amendment to the Verification Annex—5 January 1999
Section B of Part VI of the Verification Annex to the Convention
Add a new paragraph 5bis, as follows:
“For quantities of 5 milligrams or less, the Schedule 1 chemical saxitoxin shall not be subject to the notification period in paragraph 5 if the transfer is for medical/diagnostic purposes. In such cases, the notification shall be made by the time of transfer.”
[2] Amendment to the Verification Annex—14 October 2004
Insert the following paragraph after paragraph 72 in Part V of the Verification Annex:
“(72 bis) If a State ratifies or accedes to this Convention after the six‑year period for conversion set forth in paragraph 72, the Executive Council shall, at its second subsequent regular session, set a deadline for submission of any request to convert a chemical weapons production facility for purposes not prohibited under this Convention. A decision by the Conference to approve such a request, pursuant to paragraph 75, shall establish the earliest practicable deadline for completion of the conversion. Conversion shall be completed as soon as possible, but in no case later than six years after this Convention enters into force for the State Party. Except as modified in this paragraph, all provisions in Section D of this Part of this Annex shall apply.”
[3] Amendment to Schedule 1 of the Annex on Chemicals—27 November 2019
At the end of Part A of Schedule 1 of the Annex on Chemicals, add:
(13) | Р‑alkyl (H or ≤C10, incl. cycloalkyl) N‑(1‑(dialkyl(≤C10, incl. cycloalkyl)amino))alkylidene(H or ≤C10, incl. cycloalkyl) phosphonamidic fluorides and corresponding alkylated or protonated salts | ||
e.g. | N‑(1‑(di‑n‑decylamino)‑n‑decylidene)‑P‑decylphosphonamidic fluoride |
| |
Methyl‑(1‑(diethylamino)ethylidene) |
| ||
(14) | O‑alkyl (H or ≤C10, incl. cycloalkyl) N‑(1‑(dialkyl(≤C10, incl. cycloalkyl)amino))alkylidene(H or ≤C10, incl. cycloalkyl) phosphoramidofluoridates and corresponding alkylated or protonated salts | ||
e.g. | O‑n‑Decyl N‑(1‑(di‑n‑decylamino)‑n‑decylidene) |
| |
Methyl (1‑diethylamino)ethylidene)phosphoramidofluoridate | (2387496‑04‑8) | ||
Ethyl (1‑(diethylamino)ethylidene)phosphoramidofluoridate | (2387496‑06‑0) | ||
(15) | Methyl‑(bis(diethylamino)methylene)phosphonamidofluoridate | (2387496‑14‑0) | |
(16) | Carbamates (quaternaries and bisquaternaries of dimethylcarbamoyloxypyridines) | ||
Quaternaries of dimethylcarbamoyloxypyridines: | |||
1‑[N,N‑dialkyl(≤C10)‑N‑(n‑(hydroxyl, cyano, acetoxy)alkyl(≤C10)) ammonio]‑n‑[N‑(3‑dimethylcarbamoxy‑α‑picolinyl)‑N,N‑dialkyl(≤C10) ammonio]decane dibromide (n=1‑8) | |||
e.g. | 1‑[N,N‑dimethyl‑N‑(2‑hydroxy)ethylammonio]‑10‑[N‑(3‑dimethylcarbamoxy‑α‑picolinyl)‑N,N‑dimethylammonio] |
| |
Bisquaternaries of dimethylcarbamoyloxypyridines: | |||
1,n‑Bis[N‑(3‑dimethylcarbamoxy‑α‑picolyl)‑N,N‑dialkyl(≤C10) ammonio]‑alkane‑(2,(n‑1)‑dione) dibromide (n=2‑12) | |||
e.g. | 1,10‑Bis[N‑(3‑dimethylcarbamoxy‑α‑picolyl)‑N‑ethyl‑N‑methylammonio]decane‑2,9‑dione dibromide |
| |
This Act’s bill:Explanatory statement
The statute text is free to read above. View subscription options to unlock the case-law research tools for each provision.